Orogen Royalties Announces Annual Equity Compensation Grant

Rhea-AI Summary

Orogen Royalties (TSXV:OGN, OTCQX:OGNRF) has announced its annual equity compensation grants, including 324,000 Restricted Share Units (RSUs), 62,000 Deferred Share Units (DSUs), and 977,000 incentive Stock Options to directors, officers, employees, and consultants.

The RSUs will fully vest after two years, while DSUs will vest 50% each on the third and fourth anniversaries, settling upon service termination. Stock Options have a five-year term with a $1.51 exercise price, vesting over three years with 25% immediate vesting and subsequent 25% portions on the first, second, and third anniversaries.

The company's portfolio includes a 2% NSR royalty on the Ermitaño mine in Mexico and a 1% NSR royalty on the Expanded Silicon project in Nevada.

Positive

• Company maintains active equity compensation program to align management and employee interests with shareholders
• Structured vesting schedule promotes long-term retention of key personnel

Negative

• Potential dilution of shareholder value through issuance of new equity instruments
• Significant increase in share-based compensation expenses

News Market Reaction

+0.48%

1 alert

+0.48% News Effect

On the day this news was published, OGNRF gained 0.48%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

VANCOUVER, BC / ACCESS Newswire / January 31, 2025 / (TSXV:OGN)(OTCQX:OGNRF) Orogen Royalties Inc. ("Orogen" or the "Company") announces that, as part of the Company's annual share-based compensation program, the Board of Directors have authorized a grant of 324,000 Restricted Share Units (RSUs), 62,000 Deferred Share Units (DSUs), and 977,000 incentive Stock Options to directors, officers, employees, and consultants. The grant has been authorized pursuant to the Company's Omnibus Equity Incentive Compensation Plan that was approved by shareholders October 29, 2024.

The RSUs awarded will fully vest on the second anniversary of the date of grant. The DSUs awarded will vest 50% each on the third and fourth anniversaries of the grant date and will settle on the termination of service. The Stock Options have a life of five years, an exercise price of $1.51, and will vest over three years including 25% that will vest immediately followed by 25% on the first, second, and third anniversaries from the date of grant.

These equity-based compensation grants are subject to regulatory acceptance of the TSX Venture Exchange.

About Orogen Royalties Inc.
Orogen Royalties Inc. is focused on organic royalty creation and royalty acquisitions on precious and base metal discoveries in western North America. The Company's royalty portfolio includes the Ermitaño gold and silver mine in Sonora, Mexico (2% NSR royalty) being mined by First Majestic Silver Corp. and the Expanded Silicon gold project (1% NSR royalty) in Nevada, USA, being advanced by AngloGold Ashanti NA. The Company is well financed with several projects actively being explored under joint ventures.

On Behalf of the Board

OROGEN ROYALTIES INC.
Paddy Nicol
President & CEO

To find out more about Orogen, please contact Paddy Nicol, President & CEO at 604-248-8648, and Marco LoCascio, Vice President, Corporate Development at 604-248-8648. Visit our website at www.orogenroyalties.com.

Orogen Royalties Inc.
1015 - 789 West Pender Street
Vancouver, BC
Canada V6C 1H2
info@orogenroyalties.com

Forward-Looking Information
This news release includes certain statements that may be deemed "forward-looking statements". All statements in this presentation, other than statements of historical facts, that address events or developments that Orogen Royalties Inc. (the "Company") expect to occur, are forward-looking statements. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words "expects", "plans", "anticipates", "believes", "intends", "estimates", "projects", "potential" and similar expressions, or that events or conditions "will", "would", "may", "could" or "should" occur.

Although the Company believe the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results may differ materially from those in the forward-looking statements. Factors that could cause the actual results to differ materially from those in forward-looking statements include market prices, exploitation and exploration successes, and continued availability of capital and financing, and general economic, market or business conditions. Furthermore, the extent to which COVID-19 may impact the Company's business will depend on future developments such as the geographic spread of the disease, the duration of the outbreak, travel restrictions, physical distancing, business closures or business disruptions, and the effectiveness of actions taken in Canada and other countries to contain and treat the disease. Although it is not possible to reliably estimate the length or severity of these developments and their financial impact as of the date of approval of these condensed interim consolidated financial statements, continuation of the prevailing conditions could have a significant adverse impact on the Company's financial position and results of operations for future periods.

Investors are cautioned that any such statements are not guarantees of future performance and actual results or developments may differ materially from those projected in the forward-looking statements. Forward-looking statements are based on the beliefs, estimates and opinions of the Company's management on the date the statements are made. Except as required by securities laws, the Company undertakes no obligation to update these forward looking statements in the event that management's beliefs, estimates or opinions, or other factors, should change.

SOURCE: Orogen Royalties Inc

View the original press release on ACCESS Newswire

FAQ

How many RSUs, DSUs, and Stock Options did Orogen Royalties (OGNRF) grant in January 2025?

Orogen Royalties granted 324,000 RSUs, 62,000 DSUs, and 977,000 Stock Options to directors, officers, employees, and consultants.

What is the exercise price and vesting schedule for OGNRF's 2025 Stock Options grant?

The Stock Options have an exercise price of $1.51 and vest over three years: 25% immediately, followed by 25% on each of the first, second, and third anniversaries.

When do the RSUs and DSUs granted by OGNRF in 2025 vest?

RSUs vest fully on the second anniversary, while DSUs vest 50% each on the third and fourth anniversaries of the grant date.

What royalty assets does Orogen Royalties (OGNRF) currently hold?

Orogen holds a 2% NSR royalty on the Ermitaño gold and silver mine in Mexico and a 1% NSR royalty on the Expanded Silicon gold project in Nevada.